Cargando…
Case Report: A Case Report of a Histological Transformation of ALK-Rearranged Adenocarcinoma With High Expression of PD-L1 to Squamous Cell Carcinoma After Treatment With Alectinib
We report an anaplastic lymphoma kinase (ALK)-positive patient shows a poor response to the ALK inhibitor alectinib due to the high expression of programmed death-ligand 1 (PD-L1). After treatment with alectinib, the pathological form changed from adenocarcinoma into squamous cell carcinoma without...
Autores principales: | Zhang, Yan, Qin, Yaping, Xu, Hongen, Yao, Qihui, Gao, Yalan, Feng, Yushu, Ren, Jingli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262189/ https://www.ncbi.nlm.nih.gov/pubmed/34257603 http://dx.doi.org/10.3389/pore.2021.637745 |
Ejemplares similares
-
ALK Rearrangement Adenocarcinoma with Histological Transformation to Squamous Cell Carcinoma Resistant to Alectinib and Ceritinib
por: Kaiho, Taisuke, et al.
Publicado: (2020) -
Case Report: Spontaneous Remission of an Infraorbital Follicular B-Cell Lymphoma: Case Report and Review of the Literature
por: Peeters, Maxime, et al.
Publicado: (2021) -
Case Report: Mucinous Adenocarcinoma Arising From Congenital Ejaculatory Duct Cyst
por: Shen, Hua, et al.
Publicado: (2021) -
Case Report: Incidentally Discovered a Rare Cystic Lesion of Liver: Multicystic Biliary Hamartoma
por: Mu, Wentao, et al.
Publicado: (2021) -
SCG3 Protein Expression in Glioma Associates With less Malignancy and Favorable Clinical Outcomes
por: Wang, Yi, et al.
Publicado: (2021)